| Autumn Rose Wacker, MS, OTR/L | |
|
38416 Morrisonville Rd, Lovettsville, VA 20180-3102 | |
| (703) 298-5319 | |
| Not Available |
| Full Name | Autumn Rose Wacker |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 38416 Morrisonville Rd, Lovettsville, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992064752 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119005637 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Autumn Rose Wacker, MS, OTR/L 38416 Morrisonville Rd, Lovettsville, VA 20180-3102 Ph: (703) 298-5319 | Autumn Rose Wacker, MS, OTR/L 38416 Morrisonville Rd, Lovettsville, VA 20180-3102 Ph: (703) 298-5319 |
News Archive
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.
In a new development against the healthcare reform law that was signed by the President Barack Obama, 14 state Attorney Generals have filed lawsuits challenging it.
Fatigue and pain, along with other symptoms, prevent many people with multiple sclerosis (MS) from exercising. But a new how-to guide for a home-based exercise program, tested by researchers at Case Western Reserve University's nursing school and the Lerner Research Institute at the Cleveland Clinic, offers a way for people with MS to stay more physically active.
CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.
› Verified 5 days ago
Caroline Pearson Rich, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 38416 Morrisonville Rd, Lovettsville, VA 20180 Phone: 703-298-5319 | |
Mrs. Kristin Anne Sacoto, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12365 Taylorstown Rd, Lovettsville, VA 20180 Phone: 571-217-5804 |